Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

被引:36
|
作者
Kristensen, Soren L. [1 ,2 ]
Jhund, Pardeep S. [1 ]
Kober, Lars [3 ]
Preiss, David [1 ]
Kjekshus, John [4 ]
McKelvie, Robert S. [5 ]
Zile, Michael R. [6 ,7 ]
Anand, Inder S. [8 ,9 ]
Wikstrand, John [10 ]
Wedel, Hans [11 ]
Komajda, Michel [12 ,13 ]
Carson, Peter E. [14 ,15 ]
Cleland, John G. F. [16 ,17 ]
McMurray, John J. V. [1 ]
机构
[1] Univ Glasgow, BHF Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland
[2] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[3] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark
[4] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway
[5] McMaster Univ, Hamilton Hlth Sci, Hamilton, ON, Canada
[6] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA
[7] Med Univ S Carolina, Charleston, SC 29425 USA
[8] Vet Affairs Med Ctr, Minneapolis, MN USA
[9] Univ Minnesota, Minneapolis, MN USA
[10] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gothenburg, Sweden
[11] Nord Sch Publ Hlth, Gothenburg, Sweden
[12] Univ Paris 06, Hosp Pitie Salpetriere, Paris, France
[13] Inst ICAN, Paris, France
[14] Georgetown Univ, Washington, DC USA
[15] Washington DC Vet Affairs Med Ctr, Washington, DC USA
[16] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Natl Heart & Lung Inst, London, England
[17] Univ London Imperial Coll Sci Technol & Med, Harefield Hosp, Natl Heart & Lung Inst, London, England
关键词
Heart failure; Clinical trials; HF-PEF; HF-REF; Mortality; ROSUVASTATIN; TRIAL; PROGRESSION; IRBESARTAN; DESIGN; CORONA;
D O I
10.1002/ejhf.211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimsTo investigate the prognostic significance of hospitalization for worsening heart failure (WHF), myocardial infarction (MI), and stroke in patients with chronic heart failure (HF). Methods and resultsWe studied 5011 patients with HF and reduced EF (HF-REF) in the CORONA trial and 4128 patients with HF and preserved EF (HF-PEF) in the I-Preserve trial. Adjusted hazard ratios (HRs) for death were estimated for 0-30 days and 31 days after first post-randomization WHF, MI, or stroke used as a time-dependent variable, compared with patients with none of these events. In CORONA, 1616 patients (32%) had post-randomization first events (1223 WHF, 216 MI, 177 stroke), and the adjusted HR for mortality 30 days after an event was: WHF 7.21 [95% confidence interval (CI) 2.05-25.40], MI 23.08 (95% CI 6.44-82.71), and stroke 32.15 (95% CI 8.93-115.83). The HR for mortality at >30 days was: WHF 3.62 (95% CI 3.11-4.21), MI 4.41 (95% CI 3.23-6.02), and stroke 3.19 (95% CI 2.21-4.61). In I-Preserve, 896 patients (22%) experienced a post-randomization event (638 WHF, 111 MI, 147 stroke). The HR for mortality 30 days was WHF 31.77 (95% CI 7.60-132.81), MI 154.77 (95% CI 34.21-700.17), and stroke 223.30 (95% CI 51.42-969.78); for >30 days it was WHF 3.36 (95% CI 2.79-4.05), MI 3.29 (95% CI 2.14-5.06), and stroke 5.13 (95% CI 3.61-7.29). ConclusionsIn patients with both HF-REF and HF-PEF, hospitalization for WHF was associated with high early and late mortality. The early relative risk of death was not as great as following MI or stroke, but the longer term relative risk of death was similar following all three types of event. Numerically, more deaths occurred following WHF because it was a much more common event.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [31] Five-Year Outcomes of Heart Failure with Preserved Ejection Fraction
    Macia-Rodriguez, Cristina
    Paez-Guillan, Emilio
    Alende-Castro, Vanesa
    Garcia-Villafranca, Alba
    Maria Mateo-Mosquera, Lara
    Martinez-Brana, Lucia
    Valcarcel Garcia, Maria de los Angeles
    Lado Lado, Francisco Luis
    OPEN CARDIOVASCULAR MEDICINE JOURNAL, 2020, 14 : 18 - 26
  • [32] Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial
    Chatur, Safia
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Cunningham, Jonathan W.
    Docherty, Kieran F.
    Desai, Akshay S.
    Jhund, Pardeep S.
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Martinez, Felipe A.
    Shah, Sanjiv J.
    Petersson, Magnus
    Langkilde, Anna Maria
    Mcmurray, John J. V.
    Solomon, Scott D.
    CIRCULATION, 2023, 148 (22) : 1735 - 1745
  • [33] Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction
    Kajimoto, Katsuya
    Minami, Yuichiro
    Sato, Naoki
    Kasanuki, Hiroshi
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (12): : 1881 - 1887
  • [34] Comparison of Outcomes After Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction
    Aldaas, Omar M.
    Malladi, Chaitanya L.
    Mylavarapu, Praneet S.
    Lupercio, Florentino
    Darden, Douglas
    Han, Frederick T.
    Hoffmayer, Kurt S.
    Krummen, David
    Ho, Gordon
    Raissi, Farshad
    Feld, Gregory K.
    Hsu, Jonathan C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 136 : 62 - 70
  • [35] Congestive heart failure in the elderly: Comparison between reduced ejection fraction and preserved ejection fraction
    Satomura, Hajime
    Wada, Hiroshi
    Sakakura, Kenichi
    Kubo, Norifumi
    Ikeda, Nahoko
    Sugawara, Yoshitaka
    Ako, Junya
    Momomura, Shin-ichi
    JOURNAL OF CARDIOLOGY, 2012, 59 (02) : 215 - 219
  • [36] "Targeting the Heart" in Heart Failure Myocardial Recovery in Heart Failure With Reduced Ejection Fraction
    Wilcox, Jane E.
    Fonarow, Gregg C.
    Ardehali, Hossein
    Bonow, Robert O.
    Butler, Javed
    Sauer, Andrew J.
    Epstein, Stephen E.
    Khan, Sadiya S.
    Kim, Raymond J.
    Sabbah, Hani N.
    Diez, Javier
    Gheorghiade, Mihai
    JACC-HEART FAILURE, 2015, 3 (09) : 661 - 669
  • [37] Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review
    Zhirov, Igor V.
    Safronova, Natalia V.
    Tereshchenko, Sergey N.
    TERAPEVTICHESKII ARKHIV, 2023, 95 (09) : 802 - 809
  • [38] Heart failure with reduced, mildly reduced, and preserved ejection fraction: outcomes and predictors of prognosis
    Rywik, Tomasz M.
    Wisniewska, Anna
    Ceglowska, Urszula
    Drohomirecka, Anna
    Topor-Madry, Roman
    Lazarczyk, Hubert
    Polaska, Paula
    Zielinski, Tomasz
    Dorynska, Agnieszka
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2023, 133 (12):
  • [39] Acute Decompensated Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction
    Sugimoto, Tadafumi
    HEART FAILURE CLINICS, 2020, 16 (02) : 201 - +
  • [40] Heart failure with preserved ejection fraction: A precursor of heart failure with reduced ejection fraction or a distinct syndrome?
    Miani, Daniela
    Badano, Luigi P.
    De Biaggio, Paola
    Albanese, Maria Cecilia
    Ghidina, Marco
    Proclemer, Alessandro
    Fioretti, Paolo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 149 (01) : 139 - 140